| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
20,190 |
6,223 |
$126K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
17,398 |
12,328 |
$108K |
| 80053 |
Comprehensive metabolic panel |
68,105 |
46,881 |
$95K |
| 84443 |
Thyroid stimulating hormone (TSH) |
41,683 |
29,982 |
$87K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
97,779 |
61,417 |
$84K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
18,538 |
5,371 |
$83K |
| 80061 |
Lipid panel |
47,356 |
34,631 |
$42K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
2,082 |
1,899 |
$40K |
| 83721 |
|
47,108 |
34,484 |
$35K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
43,269 |
30,793 |
$24K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,932 |
1,762 |
$22K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
1,670 |
1,569 |
$21K |
| 88142 |
|
2,074 |
1,951 |
$19K |
| 82565 |
|
97,739 |
61,314 |
$17K |
| 87070 |
|
5,637 |
4,280 |
$16K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
26,416 |
17,890 |
$15K |
| 81000 |
|
44,454 |
31,537 |
$13K |
| 84153 |
|
5,337 |
4,068 |
$13K |
| 82607 |
|
19,303 |
13,724 |
$12K |
| 83970 |
|
4,285 |
2,811 |
$9K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
29,477 |
16,634 |
$7K |
| 84481 |
|
2,086 |
1,681 |
$7K |
| 84439 |
|
5,901 |
4,488 |
$7K |
| 82728 |
|
7,024 |
4,848 |
$5K |
| 82746 |
|
8,615 |
6,113 |
$4K |
| 87186 |
|
15,809 |
10,393 |
$4K |
| 36415 |
Collection of venous blood by venipuncture |
101,939 |
50,716 |
$4K |
| 87077 |
|
3,045 |
2,215 |
$3K |
| 80164 |
|
4,038 |
2,266 |
$3K |
| 80177 |
|
1,627 |
1,029 |
$3K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
649 |
487 |
$3K |
| 84436 |
|
14,247 |
10,264 |
$3K |
| 84702 |
|
239 |
228 |
$2K |
| 83550 |
|
8,704 |
6,096 |
$2K |
| 84479 |
|
10,004 |
7,432 |
$2K |
| 85610 |
|
9,099 |
4,572 |
$2K |
| 87210 |
|
745 |
662 |
$2K |
| 87088 |
|
13,230 |
8,792 |
$2K |
| 83540 |
|
10,722 |
7,486 |
$2K |
| 86703 |
|
680 |
598 |
$2K |
| 83880 |
|
943 |
619 |
$2K |
| 85730 |
|
4,837 |
3,453 |
$2K |
| 84703 |
|
372 |
354 |
$2K |
| 82270 |
|
3,917 |
2,719 |
$1K |
| 86803 |
|
1,590 |
1,219 |
$1K |
| 85651 |
|
9,938 |
7,027 |
$1K |
| 86038 |
|
702 |
547 |
$1K |
| 84550 |
|
15,453 |
10,624 |
$1K |
| 86769 |
|
1,034 |
371 |
$1K |
| 86140 |
|
4,952 |
3,469 |
$1K |
| 87340 |
|
1,647 |
1,248 |
$1K |
| 82140 |
|
2,854 |
1,648 |
$1K |
| 84403 |
|
383 |
288 |
$1K |
| 84480 |
|
2,457 |
1,668 |
$1K |
| 83002 |
|
93 |
91 |
$1K |
| 83001 |
|
95 |
93 |
$999.34 |
| 86592 |
|
1,585 |
1,272 |
$876.60 |
| 82043 |
|
7,869 |
5,673 |
$827.65 |
| 86430 |
|
1,916 |
1,431 |
$790.57 |
| 86709 |
|
1,234 |
941 |
$784.88 |
| 84134 |
|
3,184 |
2,145 |
$695.53 |
| 87324 |
|
521 |
243 |
$634.34 |
| 82652 |
|
10,434 |
7,610 |
$615.18 |
| 83090 |
|
1,065 |
786 |
$552.68 |
| 82570 |
|
4,471 |
3,131 |
$548.36 |
| 86376 |
|
71 |
67 |
$501.99 |
| P9603 |
Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled |
36,121 |
21,654 |
$494.35 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
530 |
176 |
$480.12 |
| 87177 |
|
171 |
135 |
$439.47 |
| 84144 |
|
41 |
40 |
$418.08 |
| 86403 |
|
687 |
513 |
$417.90 |
| 84100 |
|
7,524 |
5,162 |
$405.69 |
| 86063 |
|
707 |
533 |
$355.38 |
| 86696 |
|
38 |
38 |
$344.77 |
| 80076 |
|
1,766 |
1,221 |
$337.16 |
| 82378 |
|
1,018 |
730 |
$323.65 |
| 82040 |
|
918 |
603 |
$319.99 |
| 80299 |
|
849 |
595 |
$304.98 |
| 83735 |
|
5,752 |
3,904 |
$283.80 |
| 83690 |
|
810 |
606 |
$257.94 |
| 86694 |
|
37 |
37 |
$257.50 |
| 84146 |
|
17 |
17 |
$237.00 |
| 86695 |
|
38 |
38 |
$232.99 |
| 85014 |
|
1,138 |
434 |
$215.37 |
| 88141 |
|
27 |
26 |
$211.68 |
| 82150 |
|
828 |
608 |
$205.35 |
| 87045 |
|
122 |
88 |
$152.39 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
2,740 |
1,240 |
$136.01 |
| 85044 |
|
704 |
493 |
$132.88 |
| 83615 |
|
1,407 |
988 |
$113.08 |
| 82947 |
|
27 |
15 |
$73.91 |
| 86200 |
|
90 |
70 |
$47.94 |
| 86677 |
|
58 |
40 |
$46.92 |
| 84154 |
|
356 |
229 |
$43.95 |
| 80162 |
|
417 |
248 |
$40.57 |
| 84402 |
|
18 |
12 |
$40.10 |
| 86334 |
|
107 |
70 |
$34.84 |
| 84075 |
|
278 |
249 |
$32.29 |
| 82550 |
|
349 |
238 |
$29.59 |
| 82465 |
|
49 |
36 |
$20.44 |
| 84155 |
|
471 |
328 |
$20.09 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
94 |
34 |
$16.10 |
| 84466 |
|
13 |
13 |
$10.94 |
| 80185 |
|
17 |
12 |
$8.85 |
| 87449 |
|
346 |
154 |
$8.38 |
| 85018 |
|
1,371 |
512 |
$6.90 |
| 82044 |
|
17 |
13 |
$1.64 |
| 86325 |
|
26 |
12 |
$0.00 |
| 82310 |
|
34 |
28 |
$0.00 |
| 84165 |
|
182 |
129 |
$0.00 |
| 84166 |
|
13 |
12 |
$0.00 |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
231 |
140 |
$0.00 |
| 86235 |
|
24 |
14 |
$0.00 |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
2,971 |
2,234 |
$0.00 |
| G2024 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source |
3,741 |
1,288 |
$0.00 |
| 86141 |
|
90 |
55 |
$0.00 |
| 85379 |
|
204 |
121 |
$0.00 |
| 82784 |
|
126 |
41 |
$0.00 |